<a href="https://laohu8.com/S/MMSI">Merit Medical Systems</a> Reports Third-Quarter Revenue of $384.2 Million, Up 13%
Merit Medical Systems Inc. reported revenue of $384.2 million for the third quarter ended September 30, 2025, representing an increase of 13.0% compared to the same period in 2024. Constant currency revenue rose 12.5% year-over-year, while constant currency revenue, organic, increased 7.8%. The company reported a GAAP operating margin of 11.1%, up from 11.0% in the prior year period. Non-GAAP operating margin was 19.7%, compared to 19.2% in the previous year. GAAP earnings per share were $0.46, a decrease of 3.0%. Merit Medical Systems updated its full-year 2025 guidance, raising revenue and non-GAAP earnings per share expectations following the stronger-than-expected third quarter results. The company's President and CEO, Martha G. Aronson, affirmed Merit's commitment to growth initiatives and financial targets through 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merit Medical Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000856982-25-000055), on October 30, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。